Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

- PMLiVE

The AI revolution in healthcare – unlocking a new era of medical innovation

Ensuring AI tools comply with strict standards while promoting fairness, accountability and reliability

- PMLiVE

Roche’s Genentech enters $765m autoimmune disease partnership with Repertoire

The collaboration will leverage Repertoire’s immune mapping DECODE platform

Biogen Idec building

Biogen’s Skyclarys granted MHRA approval for rare movement disorder Friedreich’s ataxia

The neurodegenerative disease affects at least one in every 50,000 people in the UK

- PMLiVE

Gilead shares promising phase 3 results for Trodelvy plus Keytruda in aggressive breast cancer

Triple-negative breast cancer accounts for approximately 15% of all cases of the disease

- PMLiVE

DE&I – don’t throw the baby out with the bathwater

Diversity comes in many forms and enhances an organisation in many ways

Digital PI Compliance

Why Pharma’s Digital PI Compliance Problem Needs a Cross-Functional Fix

In many pharma teams, the responsibility for keeping prescribing information (PI) up to date online falls into a grey area. > Regulatory signs it off. > Marketing publishes it. >...

Genetic Digital

- PMLiVE

A Commitment to Elevating Patient Engagement and Integration

Medscape is honored to be the lead sponsor of the upcoming Measuring Patient Engagement Summit, taking place in Boston from April 29 to May 1. This event marks a pivotal...

Medscape Education

Content team

Exciting updates from our content and strategy team

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.

Cuttsy + Cuttsy

- PMLiVE

Pfizer’s Hympavzi granted MHRA approval to treat haemophilia A and B

More than 11,800 people were living with the genetic blood disorders in the UK in 2023/2024

- PMLiVE

BMS receives NICE recommendation for immunotherapy combination in colorectal cancer

Approximately 44,000 people are diagnosed with colorectal cancer in the UK every year

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu shows promise in first-line HER2-positive breast cancer

Up to 20% of patients with metastatic breast cancer are affected by HER2-positive disease

- PMLiVE

Tackling the antibiotic resistance crisis

With deaths from AMR having increased by over 80% among adults aged 70 and older between 1990 and 2021, and an estimated 4.71 million deaths associated with bacterial AMR in...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links